System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe

BMJ. 2005 Oct 1;331(7519):765-9. doi: 10.1136/bmj.331.7519.765.

Abstract

Low cost and effective drugs, such as magnesium sulphate, need to be included in initiatives to improve access to essential medicines in Africa

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticonvulsants / supply & distribution*
  • Drug Approval
  • Drug Costs
  • Eclampsia / drug therapy*
  • Female
  • Humans
  • Magnesium Sulfate / supply & distribution*
  • Marketing of Health Services
  • Mozambique
  • Pharmacopoeias as Topic
  • Pre-Eclampsia / drug therapy
  • Pregnancy
  • Zimbabwe

Substances

  • Anticonvulsants
  • Magnesium Sulfate